The present study demonstrated, for the first time, that T2A inhibited the angiogenesis and growth of breast cancer in vitro and in vivo through the suppression of HIF-1α protein synthesis and VEGF expression, in which the mTOR/p70S6K/4E-BP1 signaling pathway was involved. The gene discussed is EIF4EBP1; the disease is breast cancer.